Shell Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Shell Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,915	Closed	-$256K	–	1447
2020 Q4	$256K	Hold	5,915	–	–	0.01%	1053
2020 Q3	$207K	Hold	5,915	–	–	﹤0.01%	1034
2020 Q2	$316K	Sell	5,915 -76	-1%	-$3.52K	0.01%	870
2020 Q1	$213K	Sell	5,991 -91	-1%	-$4.21K	0.01%	990
2019 Q4	$290K	Sell	6,082 -143	-2%	-$5.41K	0.01%	1061
2019 Q3	$202K	Sell	6,225 -53	-0.8%	-$2.19K	﹤0.01%	1131
2019 Q2	$313K	Sell	6,278 -142	-2%	-$7.59K	0.01%	1052
2019 Q1	$433K	Hold	6,420	–	–	0.01%	970
2018 Q4	$296K	Sell	6,420 -500	-7%	-$30.9K	0.01%	984
2018 Q3	$534K	Buy	+6,920	New	+$557K	0.01%	936

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Shell Asset Management's AGIO Position: Q1 2021 in Review

Shell Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2021, closing a stake of 5,915 shares — an estimated $256K sold.

Shell Asset Management first reported a position in AGIO in Q3 2018 and held it in 10 quarters. The position peaked at $534K in Q3 2018. 174 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

Shell Asset Management reported no remaining Agios Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Shell Asset Management sold 5,915 Agios Pharmaceuticals shares in Q1 2021, an estimated $256K.
Shell Asset Management first reported a position in Agios Pharmaceuticals in Q3 2018 and held it in 10 quarters.
Shell Asset Management's Agios Pharmaceuticals position peaked at $534K in Q3 2018.
174 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on Shell Asset Management's 13F filing for Q1 2021, filed 10 May 2021.